Potent immunosuppression by a bivalent molecule binding to CD200R and TGF-βR

Transplantation

Volumn 90, Issue 2, 2010, Pages 150-159

  Gorczynski, Reginald M ^a   Chen, Zhiqi ^a   Shivagnahnam, Saaiis ^a   Taseva, Adriana ^a   Wong, Karrie ^a   Yu, Kai ^a   Khatri, Ismat ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bivalent immunosuppressant; CD200; TGF

Indexed keywords

CD200 RECEPTOR; CD200 RECEPTOR FCGLY6 TRANSFORMING GROWTH FACTOR BETA 1 FUSION PROTEIN; GLYCINE; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; PROTEIN A; RAPAMYCIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE DELETION; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LEUKOCYTE CULTURE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; CELL DIVISION; CHO CELLS; CRICETINAE; CRICETULUS; DNA PRIMERS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; SPLEEN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954951434     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e2d6a1     Document Type: Article

References (54)

1. Dujardin HC, BurlenDefranoux O, Boucontet L, et al. Regulatory potential and control of Foxp3 expression in newborn CD4(+) T cells. Proc Nat Acad Sci USA 2004; 101: 14473.
2. Morelli AE, Thomson AW. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125.
3. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170: 1304.
4. Cobbold SP, Adams E, Graca L, et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev 2006; 213: 239.
5. Stephens LA, Malpass KH, Anderton SM. Curing CNS autoimmune disease with myelin-reactiveFoxp3(+) Treg. Eur J Immunol 2009; 39: 1108.
6. Feuerer M, Hill JA, Mathis D, et al. Foxp3(+) regulatory T cells: Differentiation, specification, subphenotypes. Nat Immunol 2009; 10:689.
7. Bopp T, Jonuleit H, Schmitt E. Regulatory T cells\The renaissance of the suppressor T cells. Ann Med 2007; 39: 322.
8. Zhou X, Bailey-Bucktrout S, Jeker LT, et al. Plasticity of CD4+ FoxP3 + T cells. Curr Opin Immunol 2009; 21: 281.
9. Alard P, Clark SL, Kosiewicz MM. Mechanisms of tolerance induced by TGF beta-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF beta. Eur J Immunol 2004; 34: 1021.
10. Faunce DE, Terajewicz A, SteinStreilein J. Cutting edge: In vitro-generated tolerogenic APC induce CD8(+) T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 1991.
11. Yang L, Huang JH, Ren XB, et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1 + CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13: 23.
12. Baban B, Chandler PR, Sharma MD, et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 2009; 183: 2475.
13. Barclay AN. Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX-2 antigens. Immunology 1981; 44: 727.
14. Gorczynski RM, Chen ZQ, Yu K, et al. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin Immunol 2001; 101:328.
15. Gorczynski RM, Chen Z, Fu XM, et al. Increased expression of the novel molecule Ox-2 is involved in prolongation of murine renal allograft survival. Transplantation 1998; 65: 1106.
16. Gorczynski RM, Yu K, Clark D. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an im-munoregulatory population that inhibits alloreactivity in vitro and in vivo. JImmunol 2000; 165: 4854.
17. Hatherley D, Barclay AN. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol 2004; 34: 1688.
18. + Treg stimulated by anti-CD200R2 derived dendritic cells suppress MLCs and skin graft rejection. Transplantation 2005; 81: 1027.
19. Gorczynski RM, Chen ZQ, Kai Y, et al. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R. Transplantation 2004; 77: 1138.
20. Gorczynski RM, Hadidi S, Yu G, et al. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002; 48: 18.
21. Fallarino F, Orabona C, Vacca C, et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plas-macytoid dendritic cells. Int Immunol 2005; 17: 1429.
22. Schweitzer-Stenner R, Engelke M, Licht A, et al. Mast cell stimulation by co-clustering the type I Fc epsilon-receptors with mast cell function-associated antigens. Immunol Lett 1999; 68: 78.
23. Bai Y, Ann DK, Shen WC. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci USA 2005; 102: 7292.
24. Gorczynski RM, Chen ZQ, He W, et al. Expression of a CD200 trans-gene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 2009; 183: 1560.
25. Boudakov I, Liu J, Fan N, et al. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200. Transplantation 2007; 84: 251.
26. Gorczynski R, Chen ZQ, Kai Y, et al. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 2004; 172: 7744.
27. Gorczynski RM, Cattral MS, Chen ZG, et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo-and xenograft survival. J Immunol 1999; 163: 1654.
28. Jurgens B, Hainz U, Fuchs D, et al. Interferon-gamma-triggered in-doleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009; 114: 3235.
29. Kai G, Chen Z, Yang S, et al. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter. Transplantation 2005; 80: 394.
30. Umulis D, Oconnor MB, Blair SS. The extracellular regulation of bone morphogenetic protein signaling. Development 2009; 136: 3715.
31. Mihrshahi R, Barclay AN, Brown MH. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol 2009; 183:4879.
32. Qu YY, Zhang BJ, Zhao L, et al. The effect of immunosuppressive drug rapamycin on regulatory CD4(+)CD25(+)Foxp3(+)T cells in mice. Transpl Immunol 2007; 17: 153.
33. Gorczynski RM, Khatri I, Lee L, et al. An interaction between CD200 and mAb agonists to CD200R2 in development of dendritic cells which preferentially induce populations of CD4+CD25+Treg. J Immunol 2008; 190: 5946.
34. Fallarino F, AsselinPaturel C, Vacca C, et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004; 173: 3748.
35. Orabona C, Puccetti P, Vacca C, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006; 107: 2846.
36. Shevach EM. Mechanisms of Foxp3(+) T regulatory cell-mediated suppression. Immunity 2009; 30: 636.
37. Li MO, Flavell RA. TGF-beta: A master of all T cell trades. Cell 2008; 134: 392.
38. Waldmann H, Cobbold S. Regulatory T cells: Context matters. Immunity 2009; 30: 613.
39. Schramm C, Huber S, Protschka M, et al. TGF beta regulates the CD4+CD25+T-cell pool and the expression of Foxp3 in vivo. Int Immunol 2004; 16: 1241.
40. Brunner MC, Chambers CA, Chan FK, et al. CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813.
41. Carter LL, Fouser LA, Jussif J, et al. PD-1: PD-L inhibitory pathway affects both CD4(+)and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002; 32: 634.
42. Krieg C, Han P, Stone R, et al. Functional analysis of B and T lymphocyte attenuator engagement on CD4(+) and CD8(+) T cells. JImmu-nol2005; 175: 6420.
43. Cai GF, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: A bidirectional switch regulating T-cell activation. Immunol Rev 2009; 229: 244.
44. Haudebourg T, Dugast AS, Coulon F, et al. Depletion of LAG-3 positive cells in cardiac allograft reveals their role in rejection and tolerance. Transplantation 2007; 84: 1500.
45. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25: 9543.
46. Razmara M, Hilliard B, Ziarani AK, et al. CTLA-4.Ig converts naive CD4(+)CD25(\) T cells into CD4(+)CD25(+) regulatory T cells. Int Immunol 2008; 20: 471.
47. Thomson AW, Turnquist HR, Zahorchak AF, et al. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation 2009; 87: S86.
48. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176:6752.
49. Coquerelle C, Oldenhove G, Acolty V, et al. Anti-CTLA-4 treatment induces IL-10-producingICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. Gut 2009; 58: 1363.
50. Chung DJ, Rossi M, Romano E, et al. Indoleamine 2,3-dioxygenase- expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009; 114: 555.
51. Boasso A, Herbeuval JP, Hardy AW, et al. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4(+) T cells. Blood 2005; 105: 1574.
52. Puccetti P, Fallarino F. Generation of T cell regulatory activity by plas-macytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 2008; 40: 101.
53. Belladonna ML, Puccetti P, Orabona C, et al. Immunosuppression via tryptophan catabolism: The role of kynurenine pathway enzymes. Transplantation 2007; 84: S17.
54. Yu G, Fang M, Gong M, et al. Steady state dendritic cells with forced ID expression induce skin allograft tolerance by upregulation of regulatory T cells. Transpl Immunol 2008; 18: 208.